Reports

Ideas That Generate Results

List of Figures:

Figure 5-1: Global - Molecular Diagnostics Market (Billion US$), 2015-202
Figure 6-1: Global - Molecular Diagnostics Market by Application (%), 2015
Figure 6-2: Global - Molecular Diagnostics Market by Application (%), 2020
Figure 6-3: Global - Infectious Disease Market (Billion US$), 2015-2020 
Figure 6-4: Global - Oncology Market (Billion US$), 2015-2020
Figure 6-5: Global - Blood Screening Market (Billion US$), 2015-2020
Figure 6-6: Global - Genetic Testing Market (Billion US$), 2015-2020
Figure 7-1: Global - Molecular Diagnostics Market by Technology (%), 2015
Figure 7-2: Global - Molecular Diagnostics Market by Technology (%), 2020
Figure 7-3: Global - PCR Market (Billion US$), 2015-2020
Figure 7-4: Global - Nucleic Acid Hybridization Market (Billion US$), 2015-2020
Figure 7-5: Global - DNA Sequencing and NGS Market (Billion US$), 2015-2020
Figure 8-1: Global - Molecular Diagnostics Market by Region (%), 2015
Figure 8-2: Global - Molecular Diagnostics Market by Region (%), 2020
Figure 8-3: North America - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-4: North America - Molecular Diagnostics Market by Country (%), 2015
Figure 8-5: Europe - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-6: Europe - Molecular Diagnostics Market by Country (%), 2015
Figure 8-7: Asia Pacific - Molecular Diagnostics Market (Billion US$), 2015-2020
Figure 8-8: Asia Pacific - Molecular Diagnostics Market by Country (%), 2015
Figure 9-1: Abbott Laboratories - Break up of Revenue by Reportable Business Segment (%), 2014
Figure 9-2: Alere Inc. - Break up of Revenue by Reportable Business Segment (%), 2014
Figure 9-3: Alere Inc. - Professional Diagnostic Division Revenue by Segment (%), 2014
Figure 9-4: Becton, Dickinson and Company - Break up of Revenue by Business Segment (%), 2014
Figure 9-5: Becton, Dickinson and Company - Diagnostic Division Revenue by Segment (%), 2014
Figure 9-6: bioMérieux SA - Break up of Revenue by Applications (%), 2014
Figure 9-7: bioMérieux SA - Clinical Application Revenue by Segment(%), 2014
Figure 9-8: Cepheid - Break up of Revenue by Business Segment (%), 2014
Figure 9-9: Danaher Corporation - Break up of Revenue by Business Segment (%), 2014
Figure 9-10: Roche AG - Break up of Revenue by Business Segment (%), 2014
Figure 9-11: Roche AG - Diagnostic Division Revenue by Segment (%), 2014
Figure 9-12: Hologic, Inc. - Break up of Revenue by Business Segment (%), 2015
Figure 9-13: Hologic, Inc. - Diagnostic Division Revenue by Segment (%), 2015
Figure 9-14: QIAGEN N.V. - Break up of Revenue by Business Segment (%), 2014
Figure 9-15: Thermo Fisher Scientific Inc. - Break up of Revenue by Business Segment (%), 2014
 

List of Tables:

Table 6-1: Global - Molecular Diagnostic Market by Application (Billion US$), 2015
Table 6-2: Global - Molecular Diagnostic Market by Application (Billion US$), 2020
Table 7-1: Global - Molecular Diagnostic Market by Technology (Billion US$), 2015
Table 7-2: Global - Molecular Diagnostic Market by Technology (Billion US$), 2020
Table 8-1: Global - Molecular Diagnostic Market by Region (Billion US$), 2015
Table 8-2: Global - Molecular Diagnostic Market by Region (Billion US$), 2020
Table 9-1: Abbott Laboratories - Key Financials (Million US$), 2012-2014 
Table 9-2: Abbott Diagnostics - Product Portfolio for Molecular Diagnostics
Table 9-3: Alere Inc. - Key Financials (Million US$), 2012-2014
Table 9-4: Alere Inc. - Product Portfolio for Molecular Diagnostics
Table 9-5: Becton, Dickinson and Company - Key Financials (Million US$), 2012-2014
Table 9-6: Becton, Dickinson and Company - Product Portfolio for Molecular Diagnostics
Table 9-7: bioMérieux SA - Key Financials (Million US$) 2012-2014 
Table 9-8: bioMérieux SA - Product Portfolio for Molecular Diagnostics 
Table 9-9: Cepheid - Key Financials (Million US$), 2012-2014
Table 9-10: Cepheid - Product Portfolio for Molecular Diagnostics 
Table 9-11: Danaher Corporation - Key Financials (Million US$) 2012-2014 
Table 9-12: Danaher  Corporation - Product Portfolio for Molecular Diagnostics
Table 9-13: Roche AG - Key Financials (Million US$), 2012-2014
Table 9-14: Roche AG - Product Portfolio for Molecular Diagnostics
Table 9-15: Hologic, Inc. - Key Financials (Million US$) 2013-2015
Table 9-16: Hologic, Inc. - Product Portfolio for Molecular Diagnostics
Table 9-17: QIAGEN N.V. - Key Financials (Million US$), 2012-2014
Table 9-18: QIAGEN N.V. - Product Portfolio for Molecular Diagnostics
Table 9-19: Siemens Healthcare - Key Financials (Million US$), 2012-2014
Table 9-20: Siemens Healthcare - Product Portfolio for Molecular Diagnostics
Table 9-21: Thermo Fisher Scientific Inc. - Key Financials (Million US$) 2012-2014
Table 9-22: Thermo Fisher Scientific Inc. - Product Portfolio for Molecular Diagnostics